Amir Maafa is a seasoned Corporate Medical Director currently at MS PHARMA since 2025. Prior to this, Amir held key positions including Head of Medical at Novartis Oncology from 2018 to 2023, and NWA Cluster Medical Lead at Bayer from 2023 to 2025. Amir's extensive experience in the pharmaceutical industry also includes roles at Abbott, Bristol-Myers Squibb, AstraZeneca, and Sanofi, where they contributed to various cardiovascular and oncology initiatives. Amir earned a Doctor of Medicine (M.D.) degree from Faculté des sciences médicales between 1999 and 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices